The observation that different forms of nucleolar disruption (decrease in PARP-1 presence, or nucleolar size) are seen early in disease is an important finding that furthers the hypothesis that dysfunction of the nucleolus is a key step in the progression of AD. Here, PARP1 is linked to Alzheimer disease.